Navigation Links
Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
Date:3/1/2013

CHAPEL HILL, N.C., March 1, 2013 /PRNewswire/ -- While medical science liaisons have been around for more than 40 years, the role and activities of these medical specialists have grown quickly over the last decade. The pharmaceutical industry has long relied on medical science liaisons to forge relationships with key opinion leaders (KOLs) who can provide critical insights into the market and competition.

But the changing regulatory and access environment has altered the landscape for creating and maintaining KOL and physician relationships.

To help organizations navigate this new KOL landscape, research and consulting leader Best Practices LLC published a MSL-focused report that highlights their key pre- and post-launch activities, and service frequencies. The 78-page report presents 2011 data compared to 2009 on an array of critical activities that provide insights into how MSLs can build strong, productive relationships with KOLs and physicians. 

"Roles, Resourcing and Management of Medical Science Liaisons" provides MSL leaders with key metrics to help them create and maintain an effective MSL group. The comparative structure of the report (2011 data vs. 2009 data) also opens a window to emerging trends that will enable leaders in medical affairs – the group where MSL operations are typically housed - to set a clear direction for their MSL group going forward.

For instance, the study shows companies in 2011 were having managers oversee a greater number of MSLs than they did in 2009. In 2011, 57 percent of respondents preferred to have one manager overseeing 7-10 specialists. In 2009, the preferred span-of-control was one manger to up to six specialists (47 percent).

The key topics covered in this report include:

  • Benchmark Pre and Post-Launch Service Activities
  • Identify Drivers of Group Size & Focus
  • Gain insight into Structuring & Aligning Medical With Sales Organizations
  • Identify Optimal Call Frequencies and Service Levels with Thought Leaders
  • Identify Relationship Management Standards of Excellence
  • Value Associated with MSL
  • Budget Allocation to MSLs

The research project included observations and insights from 27 leaders with 24 companies, including 10 of the Top 20 pharma organizations. To learn more about this report, download a complimentary excerpt at http://www3.best-in-class.com/rr1205.htm.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Shows Cannabis Effects on Driving Skills
2. Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
3. University Hospitals Case Medical Center Presents Study On The Elimination Of Retained Surgical Sponges
4. MD+DI, the Global MedTech Authority, Publishes One-of-a-Kind Study with ITG Market Research on the Medical Device Outsourcing Landscape
5. New Direct-to-Consumer Prescription Delivery Channel Mitigates Risk of Medication Non-Adherence Highlighted in JAMA Internal Medicine Study
6. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
7. Study Shows Medicare Savings When Local Pharmacies Fill 90-Day Prescriptions
8. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
9. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
10. First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
11. New Study Results Published in the New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)...  Montoya Love is recognized by Continental Who,s Who ... Montoya is the Regulatory Systems Operations Manager with ... Manufacturing and selling a broad range of ... healthcare institutions, clinical laboratories and life science researchers with ... globe. ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... ... H. Van Allen have signed a joint enrollment and degree completion agreement. ... toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students ...
(Date:2/5/2016)... OR (PRWEB) , ... February 05, 2016 , ... The ... modern technology, such water may be safer than regular municipal or well water. The ... and radio host Sharon Kleyne, could go a long way toward increasing public acceptance ...
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting ... McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA ... Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly ...
(Date:2/5/2016)... ... ... In sleep, when the defenses of the day are at rest, rejected emotions ... disorders is significant self-criticism, and consequently these patients experience this disease with their feelings, ... for coping with this unease, but also leads to a reservoir of emotions that ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... inaugural Columbia University Men’s Soccer Career Development event in New York City on ... Rocco Commisso, Chairman and CEO of Mediacom, (both alumnus of the varsity Columbia ...
Breaking Medicine News(10 mins):